Veröffentlichungen

Elsässer A, Müller K, Vogt A, Strasser R, Gagel C, Schlepper M, Klövekorn W.: Assessment of myocardial viability: dobutamine echocardiography and thallium-201 single photon emission computed tomographic imaging predict the postoperative improvement of left ventricular function after bypass surgery. Am Heart J. 1998;135:463-475..

Elsässer A, Müller K-D, Skwara W, Bode C, Kübler W, Vogt A.: Severe energy deprivation of human hibernating myocardium as possible common pathomechansism of contractile dysfunction, structural degeneration, and cell death. J Am Coll Cardiol. 2002;39:1189-1198. Impact factor 7,599.

Schaper W, Vogt A, Htun P.: Die Rolle von Adenosin bei "ischemic preconditioning". Z Kardiol. 1996;85 (Suppl 6):185-190.

Strasser R, Vogt A, Schaper W.: Myokardprotektion durch Präkonditionierung. Experimentelle und klinische Bedeutung. Z Kardiol. 1996;85:79-89.

Tiefenbacher C, Bleeke T, Vahl C, Amann K, Vogt A, Kübler W.: Endothelial dysfunction of coronary resistance vessels is improved by tetrahydrobiopterin. Circulation. 2000;102:2172-2179.

Vogt A, Htun P, Arras M, Podzuweit T, Schaper W.: Intramyocardial infusion of tool drugs for the study of molecular mechanisms in ischemic preconditioning. Basic Res Cardiol. 1996;91:389-400.

Vogt A, Htun P, Kluge A, Zimmermann R, Schaper W.: Insulin-like growth factor-II delays myocardial infarction in experimental coronary artery occlusion. Cardiovasc Res. 1997;33:469-477.

Vogt A, Ackermann C, Noe T, Jensen D, Kubler W.: Simultaneous detection of high energy phosphates and metabolites of glycolysis and the Krebs cycle by HPLC. Biochem Biophys Res Commun. 1998;248:527-532. Impact factor 2,836

Vogt A, Kübler W.: Heart failure: is there an energy deficit contributing to contractile dysfunction? Basic Res Cardiol. 1998;93:1-10.

Vogt A, Ando H, Arras M, Elsässer A.: Lacking adenosine causes myocardial refractoriness. J Am Coll Cardiol. 1998;31:1134-1141.

Vogt A, Ackermann C, Yildiz M, Schoels W, Kübler W.: Lactate accumulation rather than ATP depletion predicts ischemic myocardial necrosis. Implications for the development of ischemic myocardial necrosis. Biochim Biophys Acta. 2001;1586:219-226.

Vogt A, Geyer H, Jahn L, Schänzer W, Kübler W.: Kardiomyopathie assoziiert mit unkontrollierter Selbstmedikation anaboler Steroide. Z Kardiol. 2002;91:357-362.

Vogt A, Nef H, Schaper J, Poolman M, Fell D, Kübler W, Elsässer A.: Metabolic Control Analysis of Anaerobic Glycolysis in Human Hibernating Myocardium Replaces Traditional Concepts of Flux Control. FEBS Lett. 2002;517:245-250.

Vogt A, Ackermann C, Yildiz M, Schoels W, Poolmann M, Fell D, Kübler W.: Regulation of glycolytic flux in ischemic preconditioning: a study employing metabolic control analysis. J Biol Chem. 2002;277:24411-24419.

Zimmermann R, Andres J, Brand T, Kluge A, Knöll R, Vogt A, Schaper W.: Kardiale Genexpression nach kurzen Koronarverschlüssen. Z Kardiol. 1995;84 (Suppl 4):159-165.

Vogt A, Kübler W.: Cardiac energy metabolism - a historical perspective. Heart Failure Rev. 1999;4:211-219.

Vogt A, Jensen D, Ackermann C, Kübler W.: Simultane Detektion von energiereichen Phosphaten und Metaboliten von Glykolyse und Krebs-Zyklus mittels HPLC. In: Fischer K, Jensen D, eds. Ionenanalyse mit Chromatographie und Kapillarelektrophorese. Idstein / Ts.: Dionex Corp.; 2000:201-212.

Vogt A.: Der Einfluß der Rückenmarkstemperatur auf wärmeabgebende Mechanismen bei konstanten thermischen Randbedingungen. Aachen: Verlag Shaker; 1994.

Elsasser A, Vogt A, Nef H, Kostin S, Mollmann H, Skwara W, Bode C, Hamm C, Schaper J.: Human hibernating myocardium is jeopardized by apoptotic and autophagic cell death. J Am Coll Cardiol. 2004;43:2191-2199.

Vogt A, Elsässer A, Nef H, Bode C, Kübler W, Schaper J.: Increased glycolysis as protective adaptation of energy depleted, degenerating human hibernating myocardium. Mol Cell Biochem. 2003;242:101-107.

Vogt A, Elsässer A, Pott-Beckert A, Ackermann C, Vetter S, Yildiz M, Schoels W, Fell D, Katus HA, Kübler W.: Myocardial energy metabolism in ischemic preconditioning and cardioplegia: a metabolic control analysis. Mol Cell Biochem. 2005;278:223-32.

Werle M, Kreuzer J, Höfele J, Ackermann C, Katus HA, Vogt A.: Metabolic control analysis of the Warburg effect in proliferating vascular smooth muscle cells. J Biomed Sci; 12:827-34.

Lang S, Elsässer A, Scheler C, Ackermann C, Kurz K, Tiefenbacher C, Kübler W, Katus HA, Vogt A.: Myocardial preconditioning and remote preconditioning: identifying a protective factor using proteomic methods? Basic Res Cardiol; 2006; 101:149-58

Vetter S, Elsässer A, Tutdibi O, Schoels W, Pott A, Ackermann C, Reinhard C, Wieland F, Katus HA, Kübler W, Vogt A.: Brief antecedent anoxia preserves mitochondrial function after sustained undersupply: a subcellular correlate to ischemic preconditioning? Mol Cell Biochem; 2006;285:101-6

Hippe H, Lutz S, Cuello F, Knorr K, Vogt A, Jakobs K, Wieland T, Niroomand F.: Activation of heterotrimeric G proteins by a high-energy phosphate transfer via nucleoside diphosphate kinase (NDPK) B and G beta subunits. II: specific activation of Gsalpha by a NDPK B-G beta, gamma complex in H10 cells. J Biol Chem. 2003;278:7227-7233.

van Weelden S, Fast B, Vogt A, van der Meer P, Sass J, van Hellemond J, Tielens A, Boshart M.: Procyclic trypanosoma brucei do not use Krebs cycle activity for energy generation. J Biol Chem. 2003;278:12854-12863.

Nef HM, Mollmann H, Vogt A, Weber M, Deetjen A, Dill T, Brandt R, Hamm CW, Elsässer A.: Multiple episodes of a transient global left ventricular dysfunction reminiscent to apical ballooning. Cardiology. 2007;108(1):1-3.

Vogt A, Schoels W.: Drug-eluting Stents - Grundlagen, Indikationen und klinische Ergebnisse. J Kardiol. 2003;10:331-333.